Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.22.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Operating expenses:        
Research and development $ 2,078,471 $ 1,476,430 $ 3,756,403 $ 2,683,209
General and administrative 684,877 615,965 1,464,131 1,303,901
Total operating expenses 2,763,348 2,092,395 5,220,534 3,987,110
Operating loss (2,763,348) (2,092,395) (5,220,534) (3,987,110)
Other income:        
Interest income 417 12,226 881 22,922
Net loss (2,762,931) (2,080,169) (5,219,653) (3,964,188)
Other comprehensive income (loss):        
Foreign currency translation gain (loss) 21,210 (55) 20,626 2,717
Comprehensive loss $ (2,741,721) $ (2,080,224) $ (5,199,027) $ (3,961,471)
Net loss per share:        
Basic and diluted $ (0.22) $ (0.17) $ (0.41) $ (0.32)
Weighted-average shares outstanding:        
Basic and diluted 12,632,381 12,569,933 12,618,489 12,355,867